摘要
目的探讨脉血康胶囊联合经皮冠状动脉介入术(PCI)对急性冠脉综合征患者血小板聚集率、超敏C-反应蛋白(hs-CRP)的影响。方法 124例行PCI的急性冠脉综合征患者分为RTT组(常规治疗)和MKT组(脉血康胶囊治疗)各62例。比较术前、术后12 h及术后30 d血小板聚集率、血清hs-CRP浓度。结果急性冠脉综合征患者术后12 h血小板聚集率显著升高,血清hs-CRP浓度显著上升(P<0.05);经脉血康胶囊治疗30 d后,2组血小板聚集率、hs-CRP比较有显著差异(P<0.05)。MKT组心脑血管事件发生率低于RTT组。结论脉血康胶囊可以降低PCI术后血小板聚集率与hs-CRP浓度。
Objective To explore the effect of maixuekang capsule combined with percuta- neous coronary intervention （PCI） on platelet aggregation rate and high sensitivity C-reactive protein （hs-CRP） in patients with acute coronary syndrome. Methods Totally 124 patients with acute coro- nary syndrome by PCI were divided into RTF group （conventional treatment） and MKT group （maix- uekang capsule treatment）, 62 cases in each group. Platelet aggregation rate and serum hs-CRP con- centration were compared at the time points of before operation, 12 h after operation and 30 d after operation. Results In patients with acute coronary syndrome, platelet aggregation rate significantly increased at 12 h after operation, and serum hs-CRP concentration increased significantly （P 〈 0.05）. After 30 days of treatment, there were significant differences in platelet aggregation rate and hs-CRP between two groups （P 〈 0.05 ）. The incidence rate of cardio cerebral events in MKT group was lower than that in RTT group. Conclusion Maixuekang capsule can reduce the platelet aggrega- tion rate and hs-CRP concentration in patients with acute coronary syndrome after PCI.
出处
《实用临床医药杂志》
CAS
2018年第5期42-44,共3页
Journal of Clinical Medicine in Practice
关键词
脉血康胶囊
急性冠脉综合征
经皮冠状动脉介入术
血小板聚集率
超敏C-反应蛋白
maixuekang capsule
acute coronary syndrome
percutaneous coronary inter- vention
platelet aggregation rate
high sensitivity C-reactive protein
